Joomla! provides plenty of flexibility when displaying your Web content. Whether you are using Joomla! for a blog site, news or a Web site for a company, you'll find one or more content styles to showcase your information. You can also change the style of content dynamically depending on your preferences. Joomla! calls how a page is laid out a layout. Use the guide below to understand which layouts are available and how you might use them.
BlueOakNx joins the WMS 2026 Congress as Sponsor
- Details
- Published on 10 June 2026
BlueOakNx is a Public Benefit Corporation on a mission to provide access to science-based, practitioner-grade nutraceuticals that enable a better quality of life from the inside out. The first product Mitokatylst™ - E is backed by 15 preclinical and clinical studies and 64 peer-reviewed papers. Mitokatlyst™ is the first targeted molecule clinically proven to induce mitochondrial biogenesis and boost cellular energy. This promotes skeletal muscle strength, supports metabolic function, supports cardiovascular health, and stimulates a healthy inflammatory response. As of September of 2024, 14 more clinical trials and observational studies have been independently initiated at various universities in the US, Scotland, and Sweden. Co-founder Sundeep Dugar, PhD, also leads the $101M XPrize Healthspan Semifinalist team, A New Dimension.
Learn more at www.blueoaknx.com
WMS 2026 Agenda
- Details
- Published on 12 January 2026
Mitochondria remind us that medicine cannot stay static in a complex world. They invite a dynamic approach where energy, biology, and artificial intelligence converge to treat disease, prevent illness, and support healthy longevity.
Targeting Mitochondria 2026 Agenda
- Details
- Published on 12 January 2026
Workshop: The Foundation
Opening remarks and vision for the congress by Volkmar Weissig. Setting the framework for mitochondria as dynamic, intelligent systems in the era of AI and systems medicine.
Led by Naïg Gueguen, CHU Angers, France. How to evaluate mitochondrial function beyond static measurements, addressing dynamics, interpretation challenges, adaptation, and resilience.
Posters focused on mitochondrial evaluation, methods, and innovation.
Five selected innovations from start-ups and industry showcasing how AI, imaging, and data integration are transforming mitochondrial function evaluation.
Understanding Mitochondria as a System
Fusion–fission, signaling, and inter-organelle dialogue.
Bioenergetics, redox balance, and integrated biological systems.
AI-driven imaging, modeling, and interpretation of mitochondrial complexity.
Connecting dynamics, energy, AI, and systems thinking.
From Knowledge to Action
Shared mitochondrial mechanisms across disease, prevention, and adaptation.
Therapeutic strategies, clinical translation, and prevention.
Bringing together evaluation, AI, systems biology, and therapy into a coherent vision of dynamic medicine.
Strategic perspectives and the road ahead.
Inside Extreme Longevity: The First Multi-Omics Portrait of a Supercentenarian
- Details
- Published on 28 December 2025
A groundbreaking study published in Cell Reports Medicine offers the most comprehensive molecular characterization to date of an individual with extreme human longevity. The study, authored by Eloy Santos-Pujol and led by Manel Esteller, from Josep Carreras Leukaemia Research Institute (IJC) and Universitat de Barcelona, provides fresh insights into the biological and lifestyle factors linked to healthy aging.
What the study found:
- Researchers performed a multi-omics analysis, including genome, transcriptome, metabolome, proteome, epigenome, and microbiome, on the person with the most extreme documented human lifespan.
- Despite displaying traditional molecular signs of aging, such as telomere shortening, this individual avoided common age-related diseases, highlighting a “longevity paradox”.
- Protective features included rare genetic variants, efficient lipid metabolism, low inflammation, a rejuvenated gut microbiome, and a biologically younger epigenetic profile, all linked to an extended lifespan.
Why this research matters:
This study represents a major step forward in longevity science by demonstrating that healthy aging results from the integration of molecular, biological, and lifestyle factors, rather than isolated biomarkers.
We are pleased to remind you that the World Mitochondria Society (WMS), in collaboration with the International Society of Microbiota (ISM), is organizing the Targeting Longevity World Congress 2026, taking place on April 8–9 in Berlin, Germany. You can register here.
